Itrostred SB 65mg Capsule contains Itraconazole 65mg, a triazole antifungal agent used to treat a variety of fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. Itrostred SB is typically prescribed for patients who require effective antifungal therapy with a broad spectrum of activity against dermatophytes, yeasts, and molds. The capsule formulation allows for oral administration, with absorption enhanced when taken with food. Dosage and duration of therapy depend on the type and severity of infection, and treatment should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment, congestive heart failure, or those taking concomitant medications metabolized via the cytochrome P450 system, due to potential drug interactions. Adverse effects may include gastrointestinal disturbances, headache, rash, and elevated liver enzymes. Regular monitoring of liver function tests is recommended during prolonged therapy. Itrostred SB 65mg Capsule should be used under medical supervision to ensure safety and efficacy.